Reducing the harms of xylazine: clinical approaches, research deficits, and public health context

Xylazine has emerged as a consistent part of the unregulated drug supply in recent months. We discuss major domains of xylazine’s harm, current knowledge deficits, clinical and harm reduction strategies for mi…